Abstract | BACKGROUND: PATIENTS AND METHODS: 12 patients clinically considered brain tumors underwent fluorescein sodium-guided surgery in Sun Yat-sen University Cancer Center from March 2016 to July 2017. The age of 4 female and 8 male patients ranges from 39 to 62 years. In 4 patients, corticosteroid had been prescribed before surgery due to intracranial hypertension. After injection of low dose of sodium fluorescein (3-5 mg/kg), the lesions with strong fluorescence staining were identified as the target area for biopsy or resection. RESULTS: Based on the targeted tissues with bright and homogenous fluorescence staining, all 12 patients were conclusively diagnosed as B cell non-Hodgkin's lymphoma (diffuse large cell). The specificity of the specimens sent for frozen section was 86.4% (19/22). No fluorescein sodium associated side effects were observed. CONCLUSION:
Fluorescein sodium guided surgery is an effective and safe tool in biopsy or tumor resection in patients suspicious for PCNSL with preoperative MRI presented contrast-enhanced homogenous lesions. Such technique might still be considered in those patients who have been pretreated with corticosteroid.
|
Authors | Fu-Hua Lin, Xiang-Heng Zhang, Ji Zhang, Zhen-Qiang He, Hao Duan, Chao Ke, Ke Sai, Xiao-Bing Jiang, Fuad Al-Nahari, Shao-Yan Xi, Yong-Gao Mou |
Journal | Journal of neuro-oncology
(J Neurooncol)
Vol. 139
Issue 3
Pg. 757-765
(Sep 2018)
ISSN: 1573-7373 [Electronic] United States |
PMID | 30117022
(Publication Type: Journal Article)
|
Chemical References |
- Contrast Media
- Fluorescein
|
Topics |
- Adult
- Brain Neoplasms
(diagnostic imaging, pathology, surgery)
- Contrast Media
- Female
- Fluorescein
- Humans
- Image-Guided Biopsy
- Lymphoma
(diagnostic imaging, pathology, surgery)
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Neurosurgical Procedures
- Surgery, Computer-Assisted
|